Bottom line
How much do FPHAX and IXJ overlap?
36% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 50.0% of FPHAX's assets and 31.6% of IXJ's. They share a meaningful core but differ in the rest of the portfolio.
IXJ holds far more positions (124 vs 57), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FPHAX and IXJ have in common
| Holding | % of FPHAX | % of IXJ | Overlap |
|---|---|---|---|
| ELI LILLY and CO | 28.78% | 10.93% | 10.93% |
| MERCK and CO INC | 4.74% | 4.12% | 4.12% |
| Roche Holding Ag | 4.54% | 3.75% | 3.75% |
| Astrazeneca Plc | 4.22% | 3.76% | 3.76% |
| Gilead Sciences Inc | 3.97% | 2.04% | 2.04% |
| JOHNSON and JOHNSON | 3.77% | 7.04% | 3.77% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FPHAX
- Gsk Plc — 8.17%
- Viatris Inc — 5.45%
- Ucb Sa — 5.09%
- Legend Biotech Corp — 4.53%
- Elanco Animal Health Inc — 4.15%
- Jazz Pharmaceuticals Plc — 4.09%
- Royalty Pharma Plc — 2.67%
- Fidelity Revere Street Trust — 2.44%
- Moderna Inc — 1.57%
- Intellia Therapeutics Inc — 1.19%
- Beam Therapeutics Inc — 1.10%
- Axsome Therapeutics Inc — 1.08%
- Biontech Se — 1.04%
- Xenon Pharmaceuticals Inc — 0.82%
- Ocular Therapeutix Inc — 0.80%
Only in IXJ
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
- Abbott Laboratories — 2.05%
- Novo Nordisk A/s — 1.99%
- Intuitive Surgical, Inc. — 1.83%
- Pfizer Inc. — 1.78%
- Cvs Health Corporation — 1.71%
- Vertex Pharmaceuticals Incorporated — 1.64%
- Danaher Corporation — 1.56%
- Bristol-myers Squibb Company — 1.53%
- Stryker Corporation — 1.41%
- Gsk Plc — 1.38%
Asset mix
| Asset type | FPHAX | IXJ |
|---|---|---|
| Stocks | 98.7% | 99.6% |
| Cash & short-term funds | 2.6% | 1.3% |
| Preferred stock | 0.7% | — |
| Bonds | 0.1% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Country mix
| Country | FPHAX | IXJ |
|---|---|---|
| US | 64.8% | 70.6% |
| GB | 15.1% | 5.8% |
| CH | 4.5% | 10.4% |
| BE | 5.3% | 0.5% |
| KY | 4.5% | — |
| IE | 4.1% | 1.6% |
| JP | — | 3.7% |
| DK | 0.3% | 2.3% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FPHAX and IXJ overlap?
What stocks do FPHAX and IXJ have in common?
Should I own both FPHAX and IXJ?
Which holds more stocks, FPHAX or IXJ?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.